Literature DB >> 15258567

ATM activity contributes to the tumor-suppressing functions of p14ARF.

Yanxia Li1, Dongcheng Wu, Biao Chen, Alistair Ingram, Lizhi He, Lieqi Liu, Dahai Zhu, Anil Kapoor, Damu Tang.   

Abstract

P14/p19ARF (ARF) plays a major role in the activation of p53 by oncogenic signals. The biochemical basis of this has not been fully elucidated. We report here that forced expression of p14ARF enhances phosphorylation of p53 serine 15 (p53S15) in NIH3T3, IMR90 and MCF7 cells. Ectopic expression of the oncogenes c-myc, E2F1 and E1A, all of which activate p53 at least partially via ARF, lead to p53S15 phosphorylation in IMR90 cells. In addition, ectopic expression of p53 also results in p53S15 phosphorylation, suggesting that this is a common event in the ARF-p53 tumor suppression system. Furthermore, p53-, p14ARF-, c-myc- and E2F1-, but not E1A-, induced p53S15 phosphorylation was substantially reduced in AT fibroblasts (GM05823). Downregulation of ATM in MCF7 cells using RNA interference (RNAi) technology significantly attenuated p14ARF- and p53-induced phosphorylation of p53S15. Ectopically expressed ARF in NIH3T3 cells induced ATM nuclear foci and activated ATM kinase. Functionally, ectopic expression of p14ARF and c-myc inhibited the proliferation of IMR90 but not ATM null GM05823 cells, and p14ARF-induced inhibition of MCF7 cell proliferation was significantly attenuated by downregulation of ATM by RNAi. Taken together, these data show a functional role for ATM in ARF-mediated tumor suppression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15258567     DOI: 10.1038/sj.onc.1207957

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  p14ARF activates a Tip60-dependent and p53-independent ATM/ATR/CHK pathway in response to genotoxic stress.

Authors:  Béatrice Eymin; Paule Claverie; Caroline Salon; Camille Leduc; Edwige Col; Elisabeth Brambilla; Saadi Khochbin; Sylvie Gazzeri
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

2.  MKK7 and ARF: new players in the DNA damage response scenery.

Authors:  Athanassios Kotsinas; Panagiota Papanagnou; Panagiotis Galanos; Daniel Schramek; Paul Townsend; Josef M Penninger; Jiri Bartek; Vassilis G Gorgoulis
Journal:  Cell Cycle       Date:  2014-03-26       Impact factor: 4.534

3.  Regulation of NF-kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor.

Authors:  Sonia Rocha; Michelle D Garrett; Kirsteen J Campbell; Katie Schumm; Neil D Perkins
Journal:  EMBO J       Date:  2005-03-10       Impact factor: 11.598

4.  ARF triggers cell G1 arrest by a P53 independent ERK pathway.

Authors:  Hansong Du; Weiqi Yao; Min Fang; Dongcheng Wu
Journal:  Mol Cell Biochem       Date:  2011-06-10       Impact factor: 3.396

5.  Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer.

Authors:  Georgia Velimezi; Michalis Liontos; Konstantinos Vougas; Theodoros Roumeliotis; Jirina Bartkova; Maria Sideridou; Ayguel Dereli-Oz; Maciej Kocylowski; Ioannis S Pateras; Kostas Evangelou; Athanassios Kotsinas; Ines Orsolic; Sladana Bursac; Maja Cokaric-Brdovcak; Vassilis Zoumpourlis; Dimitris Kletsas; George Papafotiou; Apostolos Klinakis; Sinisa Volarevic; Wei Gu; Jiri Bartek; Thanos D Halazonetis; Vassilis G Gorgoulis
Journal:  Nat Cell Biol       Date:  2013-07-14       Impact factor: 28.824

Review 6.  Tumour suppression by p53: a role for the DNA damage response?

Authors:  David W Meek
Journal:  Nat Rev Cancer       Date:  2009-09-04       Impact factor: 60.716

7.  hAda3 degradation by papillomavirus type 16 E6 correlates with abrogation of the p14ARF-p53 pathway and efficient immortalization of human mammary epithelial cells.

Authors:  Vladimir A Shamanin; Pedja Sekaric; Elliot J Androphy
Journal:  J Virol       Date:  2008-02-06       Impact factor: 5.103

8.  Propagation of human prostate cancer stem-like cells occurs through EGFR-mediated ERK activation.

Authors:  Adrian P Rybak; Alistair J Ingram; Damu Tang
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

9.  PTEN inhibits BMI1 function independently of its phosphatase activity.

Authors:  Catherine Fan; Lizhi He; Anil Kapoor; Adrian P Rybak; Jason De Melo; Jean-Claude Cutz; Damu Tang
Journal:  Mol Cancer       Date:  2009-11-10       Impact factor: 27.401

10.  Contactin-1 reduces E-cadherin expression via activating AKT in lung cancer.

Authors:  Judy Yan; Nicholas Wong; Claudia Hung; Wendy Xin-Yi Chen; Damu Tang
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.